Inside This Issue  by unknown
RMARCH 10, 2009
VOLUME 53, NO. 10
JOURNAL of the AMERICAN COLLEGE of CARDIOLOGY
Inside This Issue
REVIEW AND
COMMENTARYEric D. Peterson, p. 831
F
R
i
i
s
O
h
c
t
V
M
I
d
a
b
fi
C
w
cEVIEW AND COMMENTARY825Effect of Public Reporting of Outcomes on Physician BehaviorCommentary
Robert M. Califf,rederic S. Resnic, Frederick G. P. Welt
esnic and Welt reviewed the cases of the 85 in-hospital deaths that were reported at their
nstitution in a state-mandated effort to improve quality of care for percutaneous coronary
nterventions (PCIs). Over one-half of the patients who died presented with cardiogenic
hock, where PCI has been shown to be beneficial, but still associated with high mortality.
nly 13% of the deaths were plausibly related to a complication of PCI; 80% of the deaths
ad no identifiable complication of the procedure, with many of these having a severe
omorbidity such as malignancy, sepsis, or cerebrovascular accident. This review suggests that
he reporting mechanisms need to better account for high-risk patients.VIEWPOINT IEWPOINT834Announcing the Advanced Heart Failure and Transplant Cardiology Subspecialtyarvin A. Konstam, Mariell Jessup, Gary S. Francis, Douglas L. Mann, Barry Greenberg
n a Viewpoint paper, Konstam and colleagues describe the rationale behind the recent
ecision of the American Board of Medical Specialties to approve a secondary subspecialty of
dvanced heart failure and transplant cardiology. The Heart Failure Society of America has
een advocating for this change as an essential step to ensure quality of care by specialists in a
eld that has undergoing a rapid expansion of diagnostic and therapeutic options.
ertification will require a high degree of competency in all aspects of heart failure care and
ill be obtained through an additional year of subspecialty training after a traditional
ardiology fellowship or, in the first 5 years, demonstration of high quality work in the field.(continued on page A-27)
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TNTERVENTIONAL CARDIOLOGY8372-h Infusion of Eptifibatide May Be Superior to Standard 18-h InfusionEditorial Comment
Ehtisham Mahmud,nthony Y. Fung, Jacqueline Saw, Andrew Starovoytov, Cameron Densem, Percy Jokhi, Simon J. Walsh,
ebecca S. Fox, Karin H. Humphries, Eve Aymong, Donald R. Ricci, John G. Webb, Jaap N. Hamburger,
onald G. Carere, Christopher E. Buller
he recommended regimen for eptifibatide in patients undergoing percutaneous coronary
ntervention (PCI) is a double bolus followed by an 18-h infusion. Fung and colleagues
ypothesized that in uncomplicated cases, the infusion could be discontinued once adequate
latelet inhibition was achieved with clopidogrel. Over 600 patients who underwent
successful” PCI were randomized to either the standard infusion or a shorter infusion. There
as no difference in the rate of periprocedural myonecrosis or 30-day outcomes. Major
leeding was less frequent in the shorter infusion group. Following uncomplicated PCI, an
ptifibatide infusion of 2 h is noninferior to the standard 18-h infusion and may prevent
ome bleeding complications.NTERVENTIONAL CARDIOLOGY849Point-of-Care Test Identifies PCI Patients at Risk for Stent ThrombosisEditorial Comment
Elisabeth Mahla, Mark J. Antonino,
Udaya S. Tantry, Paul A. Gurbel,irk Sibbing, Siegmund Braun, Tanja Morath, Julinda Mehilli, Wolfgang Vogt,
lbert Schömig, Adnan Kastrati, Nicolas von Beckerath
everal studies have suggested that poor responders to clopidogrel are at increased risk for
tent thrombosis (ST). Most of the studies employed light transmission aggregometry (LTA)
o assess platelet reactivity, which is time-consuming. Sibbing and colleagues tested a new
oint-of-care assay, multiple electrode platelet aggregometry (MEA), which correlates well
ith LTA and returns a result within 10 min. Sixteen hundred subjects undergoing PCI,
ho had all received clopidogrel, had their blood tested with MEA and were followed for 30
ays, with a primary end point of ST. Subjects in the upper quintile of MEA (low responders
o clopidogrel) were 9.4 times more likely to have ST and were 3.2 times more likely to die.
he MEA assay had a 70% sensitivity and a 84% specificity to predict ST.(continued on page A-31)
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THILDHOOD LIPIDS AND HEART DISEASE860The Association of Pediatric Dyslipidemia With Adult Carotid IMTEditorial Commentostan G. Magnussen, Alison Venn, Russell Thomson, Markus Juonala, Sathanur R. Srinivasan,
orma S. A. Viikari, Gerald S. Berenson, Terence Dwyer, Olli T. Raitakari
n this study, Magnussen and colleagues compared the 2 classification systems of pediatric
yslipidemia (National Cholesterol Education Program [NCEP] and National Health and
utrition Examination Survey [NHANES]) for their ability to identify adolescents at risk for
ncreased carotid intima-media thickness (IMT) in adulthood. Data was combined from
lmost 2,000 adolescents who were then reassessed as young adults, age 29 to 39 years, with
n IMT measurement. High IMT in adulthood was defined as 90th percentile. There were
o significant differences between the NCEP and NHANES systems; both had high
ensitivity but low specificity. Further review found that only overweight or obese adolescents
ith dyslipidemia were likely to have high IMT as adults. These results suggest that
yslipidemia screening could be limited to overweight or obese adolescents.EART RHYTHM DISORDERS872No Benefit, No Harm With Atrial Pacing for Patients With Systolic DysfunctionEditorial Comment
Brian Olshansky,
Rakesh Gopinathannair,ruce L. Wilkoff, Peter J. Kudenchuk, Alfred E. Buxton, Arjun Sharma, James R. Cook, Anil K. Bhandari,
ichael Biehl, Gery Tomassoni, Anna Leonen, Linette R. Klevan, Alfred P. Hallstrom,
or the DAVID II Investigators
he original DAVID (Dual Chamber and VVI Implantable Defibrillator) trial randomized
atients with systolic dysfunction to dual chamber pacing at 70 beats/min or back-up only
acing; more frequent pacing was associated with worsened outcomes. Wilkoff and colleagues
ypothesized that the mode of pacing chosen for the trial (dual chamber rate-responsive
acing at 70 beats/min) was the culprit and that atrial pacing with native ventricular
onduction would be superior to back-up only pacing. The DAVID II trial randomized 600
atients with systolic dysfunction who required an implanted defibrillator to atrial pacing at
0 beats/min versus minimal ventricular pacing at 40 beats/min. There were no significant
ifferences in the combined primary end point of time to death or heart failure hospitalization
uring follow-up, or in the rates of atrial fibrillation, syncope, and quality of life measures.
hese results suggest that atrial pacing may be considered a “safe alternative” but affords noclear advantage over a mode that minimizes pacing.(continued on page A-35)
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BIOMARKERS884Little Difference in Renal Clearance of BNP and NT-proBNPEditorial Comment
Suetonia C. Palmer,oland R. J. van Kimmenade, James L. Januzzi, Jr, Jaap A. Bakker, Alphonse J. Houben, Roger Rennenberg,
braham A. Kroon, Harry J. G. M. Crijns, Marja P. van Dieijen-Visser, Peter W. de Leeuw,
igal M. Pinto
oth B-type natriuretic peptide (BNP) and amino terminal pro-B-type natriuretic peptide
NT-proBNP) inversely correlate with glomerular filtration rate (GFR). Some speculate that
T-proBNP levels may be less affected by low GFR because of cleavage of the molecule by
ndopeptidases. van Kimmenade and colleagues measured the fractional excretion (FE) of
NP and NT-proBNP by measuring the level simultaneously from the renal artery and the
enal vein. Median FEBNP was 0.21 and FENT-proBNP was 0.17. The authors conclude that
NP and NT-proBNP are equally dependent on renal function for their clearance.
